ArticleTranslational lung cancer research2022

Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis.

Juan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.